231 related articles for article (PubMed ID: 26296209)
1. Natural Killer Cells Mediate Protection against Yersinia pseudotuberculosis in the Mesenteric Lymph Nodes.
Rosenheinrich M; Heine W; Schmühl CM; Pisano F; Dersch P
PLoS One; 2015; 10(8):e0136290. PubMed ID: 26296209
[TBL] [Abstract][Full Text] [Related]
2. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.
Zhang Y; Bliska JB
Infect Immun; 2010 May; 78(5):2329-41. PubMed ID: 20231414
[TBL] [Abstract][Full Text] [Related]
3. Compartmentalization of Th1/Th2 cytokine responses to experimental Yersinia pseudotuberculosis infection in cats.
Sukura A; Higgins J; Pedersen NC
Vet Immunol Immunopathol; 1998 Oct; 65(2-4):139-50. PubMed ID: 9839869
[TBL] [Abstract][Full Text] [Related]
4. Antigen-specific lymphocyte proliferation as a marker of immune response in guinea pigs with sustained Helicobacter pylori infection.
Miszczyk E; Walencka M; Rudnicka K; Matusiak A; Rudnicka W; Chmiela M
Acta Biochim Pol; 2014; 61(2):295-303. PubMed ID: 24918491
[TBL] [Abstract][Full Text] [Related]
5. The role of V antigen in mice experimentally infected with Yersinia pseudotuberculosis; histopathological study using enzyme immunoassay.
Sugiyama Y; Kaneko K; Takashima I; Hashimoto N
Nihon Juigaku Zasshi; 1986 Aug; 48(4):781-9. PubMed ID: 3531653
[No Abstract] [Full Text] [Related]
6.
Sheppe AEF; Santelices J; Czyz DM; Edelmann MJ
Microbiol Spectr; 2021 Sep; 9(1):e0049621. PubMed ID: 34319170
[TBL] [Abstract][Full Text] [Related]
7. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
Masuda E; Maeda H
Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
[TBL] [Abstract][Full Text] [Related]
8. Yersinia pseudotuberculosis adhesins regulate tissue-specific colonization and immune cell localization in a mouse model of systemic infection.
Hudson KJ; Bouton AH
Infect Immun; 2006 Nov; 74(11):6487-90. PubMed ID: 16920785
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to Yersinia pseudotuberculosis infection is linked to the pattern of macrophage activation.
Tansini A; de Medeiros BM
Scand J Immunol; 2009 Apr; 69(4):310-8. PubMed ID: 19284495
[TBL] [Abstract][Full Text] [Related]
10. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
Ellison CA; MacDonald GC; Rector ES; Gartner JG
J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
[TBL] [Abstract][Full Text] [Related]
11. CCR2
Zhang Y; Khairallah C; Sheridan BS; van der Velden AWM; Bliska JB
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263104
[TBL] [Abstract][Full Text] [Related]
12. Critical role of T cell migration in bacterial superantigen-mediated shock in mice.
Kano H; Ito Y; Matsuoka K; Nakajima T; Iwata T; Kohsaka T; Saito H; Abe J
Clin Immunol; 2004 Feb; 110(2):159-71. PubMed ID: 15003813
[TBL] [Abstract][Full Text] [Related]
13. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
Bohn E; Autenrieth IB
J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
[TBL] [Abstract][Full Text] [Related]
14. The small RNA chaperone Hfq is required for the virulence of Yersinia pseudotuberculosis.
Schiano CA; Bellows LE; Lathem WW
Infect Immun; 2010 May; 78(5):2034-44. PubMed ID: 20231416
[TBL] [Abstract][Full Text] [Related]
15. IscR is essential for yersinia pseudotuberculosis type III secretion and virulence.
Miller HK; Kwuan L; Schwiesow L; Bernick DL; Mettert E; Ramirez HA; Ragle JM; Chan PP; Kiley PJ; Lowe TM; Auerbuch V
PLoS Pathog; 2014 Jun; 10(6):e1004194. PubMed ID: 24945271
[TBL] [Abstract][Full Text] [Related]
16. Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10.
Auerbuch V; Isberg RR
Infect Immun; 2007 Jul; 75(7):3561-70. PubMed ID: 17420232
[TBL] [Abstract][Full Text] [Related]
17. CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells.
Bergman MA; Loomis WP; Mecsas J; Starnbach MN; Isberg RR
PLoS Pathog; 2009 Sep; 5(9):e1000573. PubMed ID: 19730693
[TBL] [Abstract][Full Text] [Related]
18. Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes.
Crimmins GT; Mohammadi S; Green ER; Bergman MA; Isberg RR; Mecsas J
PLoS Pathog; 2012; 8(8):e1002828. PubMed ID: 22876175
[TBL] [Abstract][Full Text] [Related]
19. Morphogenesis of Experimental Infection Caused by Plasmid Variants of Yersinia pseudotuberculosis.
Somova LM; Drobot EI; Plekhova NG; Lyapun IN; Shubin FN
Bull Exp Biol Med; 2016 Dec; 162(2):264-268. PubMed ID: 27905039
[TBL] [Abstract][Full Text] [Related]
20. Yersinia pseudotuberculosis efficiently escapes polymorphonuclear neutrophils during early infection.
Westermark L; Fahlgren A; Fällman M
Infect Immun; 2014 Mar; 82(3):1181-91. PubMed ID: 24379291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]